From professional translators, enterprises, web pages and freely available translation repositories.
core spc for human plasma derived
core spc for human plasma derived antithrombin
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
investigation of plasma derived antithrombin products
note for guidance on the clinical investigation of plasma derived antithrombin products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
note for guidance on plasma-derived medicinal products
note for guidance on plasma- derived medicinal products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
safety and supply of plasma- derived medicinal products
safety and supply of plasma - derived medicinal products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
clinical investigation of plasma derived factor viii and ix products
clinical investigation of plasma derived factor viii and ix products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
addendum to note for guidance on plasma-derived medicinal products
addendum to note for guidance on plasma- derived medicinal products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
core spc for human plasma derived and recombinant coagulation factor ix products
core spc for human plasma derived and recombinant coagulation factor ix products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
titolo del documento note for guidance on plasma-derived medicinal products
titel på dokumentet note for guidance on plasma- derived medicinal products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
immunoglobulin for intravenous administration (ivig) core spc for human plasma derived and
core spc for human normal immunoglobulin for intravenous administration (ivig)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
investigation of human plasma derived factor viii and ix products note for guidance on the clinical
note for guidance on the clinical investigation of human plasma derived factor viii and ix products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
the expiry date of products incorporating plasma-derived products as stabilisers or excipients:
the expiry date of products incorporating plasma- derived products as stabilisers or excipients:
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
core spc for human plasma derived antithrombin note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use
core spc for human plasma derived antithrombin note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
documento concettuale concept paper on gene therapy concept paper on the development of a cpmp guideline on comparability of biotechnology-derived products
konceptdokumenter concept paper om gene therapy concept paper on the development of a cpmp guideline on comparability of biotechnology- derived products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
(6) the funding of both the charitable trust and the sdt are both derived from a reserve fund set up by the sic.
(6) the funding of both the charitable trust and the sdt are both derived from a reserve fund set up by the sic.
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
titolo del documento note for guidance on the clinical investigation of plasma derived fibrin sealants note for guidance on the clinical investigation of von willebrand factor warning on transmissible agents for patient leaflets and spcs core spc for plasma derived fibrin sealants
titel på dokumentet note for guidance on the clinical investigation of plasma derived fibrin sealants note for guidance on the clinical investigation of von willebrand factor warning on transmissible agents for patient leaflets and spcs core spc for plasma derived fibrin sealants
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
the other 50 % may only be financed by the beneficiaries own contribution, derived either from his own savings or from any interest-free family loan.
the other 50 % may only be financed by the beneficiaries own contribution, derived either from his own savings or from any interest-free family loan.
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
contribution to part s.2.3 of the structure of the dossier for applications for marketing authorisation – control of starting materials for the production of plasma-derived medicinal products
contribution to part s. 2. 3 of the structure of the dossier for applications for marketing authorisation – control of starting materials for the production of plasma- derived medicinal products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.